Trademark Overview
On Thursday, March 26, 2026, a trademark application was filed for WUXITECAN-2 with the United States Patent and Trademark Office. The USPTO has given the WUXITECAN-2 trademark a serial number of 99726259. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, March 26, 2026. This trademark is owned by WuXi XDC Cayman Inc.. The WUXITECAN-2 trademark is filed in the Chemical Products, Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations for inhibiting tumors; Pharmaceutical products for the prevention and treatment of cancer; Biological preparations for the treatment of cancer; Biological preparations for use in cell cultures for medical purposes; Chemical reagents for medical or veterinary purposes; Chemical reagents for medical purposes; Antibodies for medical purposes; Biologics in the nature of cells for the treatment of cancer
Custom manufacture of pharmaceuticals; Custom manufacturing of pharmaceuticals; Manufacturing services for others in the field of antibody drug
conjugates and intermediates thereof; Custom manufacture of pharmaceutical
preparations, biomedical preparations, drug conjugates, anti-body drug
conjugates, chemical reagents; Biomanufacturing for others of pharmaceuticals using biological organisms in the manufacturing process
Active chemical ingredients for use in the manufacture of pharmaceuticals; Chemical reagents, other than for medical or veterinary purpose; Biochemical catalysts; Biological preparations for use in the manufacture of pharmaceuticals; Chemical preparations for scientific purposes, other than for medical or veterinary use; Heterocyclic compounds; Chemical preparations for use in the manufacture of pharmaceuticals; Antibody reagents used for the detection of antigens in cells and tissue, other than for medical or veterinary purposes
Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Research and development services of new pharmaceutical products; Research and development of antibody-drug conjugates; Research and development of conjugated antibodies; Product development consulting in the field of pharmaceuticals, anti-bodies, conjugated antibodies, chemical reagents; Product development for others; Biomedical research services; Scientific research in the nature of conducting clinical trials for others in the field of new
pharmaceutical development